These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8519640)

  • 1. Biology and pharmacology of thiopurines.
    Aarbakke J
    Pediatr Hematol Oncol; 1995; 12(5):511-9. PubMed ID: 8519640
    [No Abstract]   [Full Text] [Related]  

  • 2. Thiopurine biology and pharmacology.
    Aarbakke J; Janka-Schaub G; Elion GB
    Trends Pharmacol Sci; 1997 Jan; 18(1):3-7. PubMed ID: 9114722
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
    Hawwa AF; Millership JS; Collier PS; Vandenbroeck K; McCarthy A; Dempsey S; Cairns C; Collins J; Rodgers C; McElnay JC
    Br J Clin Pharmacol; 2008 Oct; 66(4):517-28. PubMed ID: 18662289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
    Relling MV; Gardner EE; Sandborn WJ; Schmiegelow K; Pui CH; Yee SW; Stein CM; Carrillo M; Evans WE; Klein TE;
    Clin Pharmacol Ther; 2011 Mar; 89(3):387-91. PubMed ID: 21270794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism.
    Lennard L; Lilleyman JS
    Ther Drug Monit; 1996 Aug; 18(4):328-34. PubMed ID: 8857546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing treatment with thioguanine derivatives in inflammatory bowel disease.
    Louis E; Belaiche J
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):37-46. PubMed ID: 12617881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-MP metabolite levels: a potential guide to Crohn's disease therapy.
    Sandborn WJ
    Gastroenterology; 1997 Aug; 113(2):690-2. PubMed ID: 9247497
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the pharmacogenomics of thiopurine methyltransferase.
    Coulthard SA; Hall AG
    Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
    Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
    Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.
    Colletti RB
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):282-3. PubMed ID: 16954947
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man.
    Bertino JR
    Arthritis Rheum; 1973; 16(1):79-83. PubMed ID: 4540289
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
    Lennard L; Welch JC; Lilleyman JS
    Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M; Theede K; Nielsen AM
    Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human thiopurine methyltransferase: no evidence of activation by its substrates.
    Stupans I; Kirlich A; McKinnon RA
    Life Sci; 1998; 62(4):343-50. PubMed ID: 9450506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.
    Lancaster DL; Lennard L; Rowland K; Vora AJ; Lilleyman JS
    Br J Haematol; 1998 Jul; 102(2):439-43. PubMed ID: 9695957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells.
    Lennard L; Maddocks JL
    J Pharm Pharmacol; 1983 Jan; 35(1):15-8. PubMed ID: 6131958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing immunomodulator therapy for inflammatory bowel disease.
    Dubinsky MC
    Curr Gastroenterol Rep; 2003 Dec; 5(6):506-11. PubMed ID: 14602061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia.
    Higgerson K; Flatt T
    J Pediatr Hematol Oncol; 2023 May; 45(4):e514-e517. PubMed ID: 37027323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease.
    Gupta P; Gokhale R; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):450-4. PubMed ID: 11698762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances in pharmacogenomics of mercaptopurine].
    Chen XX; Shen SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):1027-1033. PubMed ID: 28899477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.